ClinicalTrials.Veeva

Menu

Study of Personalized Dietary Intervention for the Control of Essential Hypertension (PCFADASH-HT)

U

University of Nigeria, Enugu Campus

Status

Unknown

Conditions

Essential Hypertension

Treatments

Other: conventional DASH diet counselling
Other: PCFA interventional dietary counselling

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT02136264
PCFADASH-HT

Details and patient eligibility

About

An ongoing case study of psoriasis, shows reproducibly that ingestion of hydrogenated fats, and some flavourant or sweetener compounds, leads to relapse of psoriasis, and secondary food intolerances, followed by remission over a couple of months (cpcpsoriasis.blogspot.com). Hence a personalized categorical food avoidance diet averts relapse and maintains remission of psoriasis, with side benefit on blood pressure and other metabolic parameters (J Hypertension 2012; 30: e-suppl 1, poster 158). Study hypothesis: this dietary approach would improve the control of essential hypertension. A randomized controlled clinical trial is proposed to compare this dietary approach with conventional DASH-type dietary counselling. 40 study participants will be randomly assigned to either conventional or interventional dietary counselling. They will be comprehensively monitored (including gene expression studies) for two years. Outcome criteria will include blood pressure, complications of hypertension, side-benefit on comorbidity, and requirement for antihypertensive drugs.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. average blood pressure exceeds 160/100mm Hg (140/90 if additional vascular risk), regardless of whether on treatment
  2. on one or two antihypertensive drugs AND average BP exceeds 140/90 (130/80 if additional risk)
  3. on three or more antihypertensives, regardless of whether BP controlled
  4. sufficiently literate to follow detailed dietary instructions
  5. informed consent

Exclusion criteria

  1. disabling complications of hypertension
  2. secondary cause of hypertension
  3. pregnancy
  4. age less than 18 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

50 participants in 2 patient groups

PCFA interventional dietary counselling
Active Comparator group
Description:
personalized categorical food avoidance dietary counselling
Treatment:
Other: PCFA interventional dietary counselling
conventional DASH diet counselling
Sham Comparator group
Description:
DASH = conventional "dietary approach to stop hypertension"
Treatment:
Other: conventional DASH diet counselling

Trial contacts and locations

1

Loading...

Central trial contact

Nnamdi Nwosu, MB BS FWACP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems